AbbVie Inc. Amgen Inc. AstraZeneca plc
Bristol-Myers Squibb Company
Daiichi Sankyo Company Limited
Eli Lilly and Company
F. Hoffmann-La Roche AG
GlaxoSmithKline plc. Johnson & Johnson
Merck & Co. Inc. Novartis International AG
Published | Pages | Publisher | Report code |
---|---|---|---|
May 2022 | 72 | GEN Consulting | ASDR-599956 |
AbbVie Inc. Amgen Inc. AstraZeneca plc
Bristol-Myers Squibb Company
Daiichi Sankyo Company Limited
Eli Lilly and Company
F. Hoffmann-La Roche AG
GlaxoSmithKline plc. Johnson & Johnson
Merck & Co. Inc. Novartis International AG